All research papers

Radiation-free or Chemo-free: Rethinking the Best Strategy for PD-L1-High, Unresectable Stage III NSCLC.

Occult Maxillary Sinus Phosphaturic Mesenchymal Tumor Localized by 68Ga-DOTATATE PET/CT After Repeated Negative Parathyroid Imaging.

[¹⁸F]AlF-FAPI-74 PET/CT for preoperative assessment of the peritoneal cancer index and comparison with MRI-based, surgical and pathological assessment in colorectal cancer patients eligible for CRS-HIPEC: study protocol for a prospective observational proof-of-concept study.

Spatial distribution of X-ray attenuation in a full-face shield: a multipoint in vivo study in interventional cardiology.

Stereotactic radiosurgery for brain metastases from male breast cancer: a multicenter retrospective study.

Glypican-3-Targeted Paired Radiotheranostics in Orthotopic Liver Cancer Models.

Tumour-to-Kidney Absorbed Dose Ratios for Alpha-Emitter PRRTs Estimated with [¹⁷⁷Lu]Lu-DOTATATE SPECT Images and Biokinetic Models: Patient Variations Impact Contribution from Redistributing Daughters.

Recurrent C19MC-altered embryonal tumors with multilayered rosettes: outcomes of stereotactic radiosurgery.

Stereotactic Radiosurgery for Thalamic Brain Metastases: A Retrospective Analysis and Literature Review.

Comparative Evaluation of [99mTc]Tc-HYNIC-FAPI-04 and [99mTc]Tc-HYNIC-FAPI-46 for FAP-Targeted SPECT Imaging.

Dual-Target Nectin-4/FAP Heterobivalent Probe ⁶⁸Ga/¹⁷⁷Lu-FZ-NF-1 for Triple-Negative Breast Cancer: Preclinical Theranostic Evaluation and First-in-Human Translation.

Somatostatin Receptor-Expressing Hibernoma Mimicking Malignancy on SSTR-PET in MEN1: A Diagnostic Pitfall.

Extraskeletal Ewing Sarcoma Involving the Abdominal Cavity and Retroperitoneum on 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT.

Editorial: Diagnosis, treatment and prognosis of neuroendocrine neoplasms with a focus on peptide receptor radionuclide therapy (PRRT)

Fulminant extramedullary relapse of multiple myeloma with rare cardiac, vascular, and multivisceral involvement: A case report.

LINAC-based stereotactic radiosurgery targeting the hippocampus in mesial temporal lobe epilepsy: a single-center case series.

Dual‐Target Nectin‐4/FAP Heterobivalent Probe 68Ga/177Lu‐FZ‐NF‐1 for Triple‐Negative Breast Cancer: Preclinical Theranostic Evaluation and First‐in‐Human Translation

Heterobivalent fibroblast activation protein-targeted Radiotheranostic ligands integrating cyclic peptide and small-molecule motifs for enhanced tumor retention.

Prostate-specific membrane antigen in malignant brain tumors: vascular heterogeneity, imaging promise, and therapeutic challenges

External validation of the bellmunt risk score for survival prediction in mCRPC patients undergoing [177Lu]Lu-PSMA-617 therapy

Organ and tumor dosimetry of [161Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC

Deep learning for automatic detection of prostatectomy in CT images of prostate cancer patients.

First-in-human evaluation of 225Ac-PSMA-Trillium™ (BAY 3563254; 225Ac felivotide mopaxetan) in metastatic castration-resistant prostate cancer: the phase 1 PAnTHA study

Large Calyceal Diverticulum Mimicking a Solid Renal Mass in a Patient Undergoing 68Ga-DOTATATE PET/CT.

Exposure of unmonitored workers to ionizing radiation due to portable X-ray machine use and area dose mapping in an emergency department in King Abdulaziz Medical City, Jeddah.

Automated workflow for target volume propagation in online adaptive magnetic resonance guided radiotherapy for lung lesions using foundation models.

One-step flow synthesis and [⁶⁸Ga]Ga radiolabelling of metal phenolic network nanoparticles for in vivo PET tracking.

The role of particle therapy in the treatment of locally recurrent rectal cancer: a systematic review.

Peptide Receptor Radionucleotide Therapy for Unresectable Paediatric Head and Neck Paraganglioma in Aotearoa New Zealand.

Lutetium-177 radiopharmaceuticals in cancer care: progress and challenges

Salvage treatment strategies for recurrence after radical prostatectomy: Current status, challenges, and future directions

Metal artifact reduction for 3 T MRI-only prostate radiotherapy in patients with hip prostheses: impact on target definition, synthetic CT generation, dose calculation, and fiducial marker identification.

Nanoparticle-Based Strategies to Enhance PSMA-Targeted Radioligand Therapy: A Review of the Delivery, Co-Formulation, and Combination Landscape Surrounding Lutetium Lu 177 Vipivotide Tetraxetan (Pluvicto)

Upright Immobilization for Proton Therapy: A Critical Review and Single-Institution Experience.

Corrigendum to 'Explainability-informed benchmarking of two deep learning models for organ-at-risk segmentation in MR-guided adaptive radiotherapy' [Journal of Medical Imaging and Radiation Sciences 57/3 (2026) 102200].

Learning-enhanced hybrid planar-SPECT dosimetry for voxel-level Monte Carlo dose estimation in radionuclide therapy.

Three Cases of Merkel Cell Carcinoma Treated With Lutetium-177 Oxodotreotide.

Effective treatment of carcinoid syndrome with peptide receptor radionuclide therapy.

Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial.

Correlation of ⁶⁸Ga-DOTATATE and ¹⁸F-FDG PET/CT Uptake Parameters with PASS and GAPP Scores in Pheochromocytoma.

Experimental radiotherapy with the gastrin-releasing peptide receptor (GRPR) antagonist [177Lu]Lu-AU-SAR-M1 in a prostate cancer murine model using reduced-frequency dosing

Single-fraction stereotactic radiosurgery vs. hypofractionated stereotactic radiotherapy for resected brain metastases: a systematic review and meta-analysis of comparative studies.

Site-specific performance and complexity-dependent risk assessment of patient-specific quality assurance using a 2D array detector in CyberKnife radiosurgery.

Topology-preserved transformer-based CBCT-CT registration via normalized gradient field guidance for nasopharyngeal carcinoma.

Discordant ¹⁸F-FDG and ⁶⁸Ga-DOTATATE PET/CT Findings Before Radionuclide Therapy in Small Cell Lung Cancer.

How reliable is deep inspiration breath hold at CT simulation? Clinical impact of surface-guided breathing training in breast cancer radiotherapy.

Correlation of [¹⁸F]SiTATE-PET-tracer with somatostatin receptor expression in meningiomas: an exploratory ex vivo histological pilot study.

Isotope Harvesting at the Facility for Rare Isotope Beams: Progress and Current Status.

Recombinant human thyrotropin reducing insulin resistance in patients with differentiated thyroid cancer.

Intermediate risk thyroid cancer management: physician survey.

Fibroblast activation protein-α in liver fibrosis and hepatocarcinogenesis: Stromal remodeling, molecular imaging, and theranostic targeting.

Brain metastasis: Opportunities for novel therapies.

Discrepancy between Collapsed Cone and Monte Carlo algorithms in lung inhomogeneity correction.

Optimizing the therapeutic ratio of PSMA-PET-guided para-aortic radiotherapy for prostate cancer: A systematic review and structured quantitative synthesis.

Solitary Flat Bone Metastasis of Follicular Thyroid Carcinoma: Complete Molecular and Partial Structural Response After 2 ¹³¹I Therapies.

Radiomics on ¹⁷⁷Lu-DOTATATE Posttreatment Scans: Feasibility, Preprocessing Optimization, and Planar-SPECT Comparison.

A Prospective, Single-Center, Single-Arm, Exploratory Study of ¹⁷⁷Lu-LNC1010 Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors.

Strategic driving of the cancer-immunity cycle in HCC: roles of immune, molecular-targeted, and locoregional therapies.

Feasibility of dose accumulation for assessing treatment-related side effects in MR-guided abdominal SABR: A single-institution study.

SSTR-Targeted Radiotheranostics in Breast Cancer: A Comparison of [⁶⁸Ga]Ga-DOTATOC and [⁶⁸Ga]Ga-SSO120 with [¹⁸F]FDG PET.